词条 | Amyris (company) |
释义 |
| name = Amyris, Inc. | logo = Wiki-Amyris Purple.png | type = Public | traded_as = {{NASDAQ|AMRS}} Russell 2000 Index component | foundation = 2003 | location = Emeryville, California, USA | industry = Renewable Fuels, Anti-Malaria, Renewable Chemicals, Renewable Products | revenue = {{profit}} $143.4 million | key_people = John Melo: CEO Joel Cherry: President Kathleen Valiasek: CFO Eduardo Alvarez: COO Nicole Kelsey: Gen.Counsel & Secretary | homepage = {{URL|http://www.amyris.com/}} | num_employees = 300–350 }} Amyris {{NASDAQ|AMRS}} is a science and technology leader in the research, development and production of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets. Amyris applies its exclusive, advanced technology, including state-of-the-art machine learning, robotics and artificial intelligence to engineer yeast, that when combined with sugarcane syrup through fermentation, is converted to highly pure molecules for specialty ingredients. Amyris manufactures sustainably-sourced ingredients at industrial scale for B2B partners and further distribution to 2,000 of the world’s top brands, reaching more than 200 million consumers. Amyris stands by its No Compromise™ promise that everything it makes is sustainably sourced, performs better, costs less, has higher purity and is better for people and the planet than products made with existing processes. Amyris also owns Biossance – the fastest-growing, clean skincare brand in the US that delivers No Compromise™ beauty. More information about the company is available at www.amyris.com The company went public on NASDAQ in October 2010 (AMRS) but as of January 2013, was trading at less than 30% of its initial offering price due to lack of commercial success in cost-effectively producing "drop in" synthetic transportation fuel, which was to be its initial, major focus. The firm has now focused its attention on higher-priced and higher-margin products that are not in the transportation fuel area [1] Renewable fuelsAmyris' technology platform, branded "No Compromise," is focused on providing high performance petroleum-alternatives, using sustainable feedstock such as sugarcane. Amyris is establishing the partnerships and capabilities needed to bring the renewable diesel fuel to market. A few of these actions include:
ArtemisininArtemisinin is a compound naturally found in the Chinese Sweet Wormwood plant effective in the treatment of malaria. Its production is hampered by difficult climate and agricultural conditions. Institute for OneWorld Health received a grant from the Bill and Melinda Gates Foundation to develop and produce non-seasonal, high-quality, affordable artemisinin, and engaged Amyris Biotechnologies and Sanofi to assist on certain parts of the project, which is near completion, based on technology from UC Berkeley, NRC Canada, and other sources. Media coverage
References1. ^Fast Company Magazine (8 August 2012), "The Rise and Fall of the Company That Was Going to Have Us All Using Biofuels." External links
6 : Companies based in Emeryville, California|Biotechnology companies of the United States|Biotechnology companies established in 2003|Companies listed on NASDAQ|2003 establishments in California|American companies established in 2003 |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。